Phathom Pharmaceuticals Inc (NAS:PHAT)
$ 10.61 -0.25 (-2.3%) Market Cap: 846.21 Mil Enterprise Value: 831.61 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 23/100

Phathom Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript

Mar 11, 2026 / 07:30PM GMT
Release Date Price: $11.15 (+0.32%)
Jenna Davidner
Barclays Services Corp - Equity Analyst

All right. I think we're ready to go. Welcome to the last presentation of the day at the Barclays Miami Healthcare Conference. My name is Jenna Davidner. I'm one of the analysts on the specialty pharmaceuticals team here.

And on the stage with me, I have Phathom Pharmaceuticals and representing the company is the CEO, Steve Basta; and the CFO, Sanjeev Narula. Thank you both for joining us.

Steven Basta
Phathom Pharmaceuticals Inc - President, Chief Executive Officer, Director

Jenna, thanks for the invitation.

Questions & Answers

Jenna Davidner
Barclays Services Corp - Equity Analyst

So let's start. There's a lot of things that has happened at the company over the past couple of years. And specifically, both of you are very new to the company, Sanjeev even more recent. So starting with you, Steve, just talk us through what attracted you to this opportunity? And maybe when you got on board, what were some of the biggest initiatives that you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot